Prostate Disease Severity Score: In the management of benign enlargement of prostate

K. N. Sanman, Santosh Patil, GG Laxman Prabhu, Ranjit Shetty, P. Venugopal

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: Developing a simple, user-friendly objective severity scoring system for symptomatic benign enlargement of prostate (BEP) and comparing with International Prostate Symptom Score (IPSS). Subjects and Methods: In this prospective study, patients with BEP completed IPSS proforma. A grading system was developed for peak flow of urine (Qmax), transitional zone index (TZI), detrusor wall thickness (DWT) and intravesical prostatic protrusion (IPP). Prostate Disease Severity Score (PDSS) was developed as sum of the variables. Results: Among 115 patients, obstructive voiding (70.43%) was predominant symptom followed by storage symptom (10.44%). Among predominant obstructive voiders, grades 1–3 TZI was common (97.53%), followed by IPP (64.19%) and DWT (62.96%) of varying grade. IPP, DWT, TZI and Qmax proved to be strong determinants of obstructive voiding (p < 0.05). The components of PDSS correlated well with total score (p < 0.05), positively correlated with IPP, DWT and TZI, and negatively with Qmax (p < 0.05); correlation with IPSS was statistically significant (p < 0.05). According to PDSS, 92.5% (37/40) patients with severe, 73.02% (46/63) with moderate, 8.33% (1/12) with mild degree of obstruction needed surgical intervention. Conclusion: The objective nature, comparable correlation with IPSS, potentiality to predict future need for surgical intervention, makes PDSS, a potential user-friendly assessment tool in management of BEP. Level of evidence: Not applicable.

Original languageEnglish
Pages (from-to)26-32
Number of pages7
JournalJournal of Clinical Urology
Volume17
Issue number1
DOIs
Publication statusAccepted/In press - 2022

All Science Journal Classification (ASJC) codes

  • Surgery
  • Urology

Fingerprint

Dive into the research topics of 'Prostate Disease Severity Score: In the management of benign enlargement of prostate'. Together they form a unique fingerprint.

Cite this